AU782870C - The use of 5HT4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions - Google Patents

The use of 5HT4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions

Info

Publication number
AU782870C
AU782870C AU29162/02A AU2916202A AU782870C AU 782870 C AU782870 C AU 782870C AU 29162/02 A AU29162/02 A AU 29162/02A AU 2916202 A AU2916202 A AU 2916202A AU 782870 C AU782870 C AU 782870C
Authority
AU
Australia
Prior art keywords
prophylaxis
treatment
receptor antagonists
cardiovascular conditions
certain cardiovascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU29162/02A
Other versions
AU2916202A (en
AU782870B2 (en
Inventor
Neeta Balkrishan Amin
Mireille Marguerite Jeanne Bonhomme
Antoine Michel Alain Bril
Bernard Emile Joseph Gout
Bernard Enno Ilson
Gillian Louise Shepherd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire GlaxoSmithKline SAS
Glaxo Group Ltd
Original Assignee
Laboratoire GlaxoSmithKline SAS
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire GlaxoSmithKline SAS, Glaxo Group Ltd filed Critical Laboratoire GlaxoSmithKline SAS
Priority to AU29162/02A priority Critical patent/AU782870C/en
Publication of AU2916202A publication Critical patent/AU2916202A/en
Application granted granted Critical
Publication of AU782870B2 publication Critical patent/AU782870B2/en
Assigned to GLAXO GROUP LIMITED, LABORATOIRE GLAXOSMITHKLINE S.A.S. reassignment GLAXO GROUP LIMITED Alteration of Name(s) of Applicant(s) under S113 Assignors: GLAXO GROUP LIMITED, LABORATOIRE GLAXOSMITHKLINE S.A.S., SMITHKLINE BEECHAM CORPORATION
Publication of AU782870C publication Critical patent/AU782870C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU29162/02A 2000-08-07 2002-03-27 The use of 5HT4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions Ceased AU782870C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU29162/02A AU782870C (en) 2000-08-07 2002-03-27 The use of 5HT4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB0019410 2000-08-07
GB0019523 2000-08-08
GB0019524 2000-08-08
GB0118919 2001-08-02
GB0119022 2001-08-03
AU29162/02A AU782870C (en) 2000-08-07 2002-03-27 The use of 5HT4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU76529/01A Division AU781276B2 (en) 2000-08-07 2001-08-07 The use of 5HT4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions

Publications (3)

Publication Number Publication Date
AU2916202A AU2916202A (en) 2002-05-23
AU782870B2 AU782870B2 (en) 2005-09-08
AU782870C true AU782870C (en) 2007-03-15

Family

ID=35006586

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29162/02A Ceased AU782870C (en) 2000-08-07 2002-03-27 The use of 5HT4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions

Country Status (1)

Country Link
AU (1) AU782870C (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018036A1 (en) * 1992-03-12 1993-09-16 Smithkline Beecham Plc Condensed indole derivatives as 5ht4-receptor antagonists
WO1998007728A1 (en) * 1996-08-16 1998-02-26 Smithkline Beecham Plc PROCESS FOR THE PREPARATION OF N-[(1-nBUTYL-4-PIPERIDYL)METHYL] -3,4-DIHYDRO -2H-[1,3] OXAZINO[3,2-a] INDOLE-10-CARBOXAMIDE AND SALTS AND INTERMEDIATES IN THE PROCESS

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018036A1 (en) * 1992-03-12 1993-09-16 Smithkline Beecham Plc Condensed indole derivatives as 5ht4-receptor antagonists
EP0884319A2 (en) * 1992-03-12 1998-12-16 Smithkline Beecham Plc [1,3]oxazino[3,2-A]indole derivative
WO1998007728A1 (en) * 1996-08-16 1998-02-26 Smithkline Beecham Plc PROCESS FOR THE PREPARATION OF N-[(1-nBUTYL-4-PIPERIDYL)METHYL] -3,4-DIHYDRO -2H-[1,3] OXAZINO[3,2-a] INDOLE-10-CARBOXAMIDE AND SALTS AND INTERMEDIATES IN THE PROCESS

Also Published As

Publication number Publication date
AU2916202A (en) 2002-05-23
AU782870B2 (en) 2005-09-08

Similar Documents

Publication Publication Date Title
IL144147A0 (en) Regulators of the pct or smoothened pathway, compositions and uses related thereto
HK1078266A1 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
ZA200004362B (en) Use of CRF antagonists and related compositions.
HUP0200442A3 (en) Azeotrope-like composition comprising 1,1,1,3,3-pentafluorobutane and its use
AU8179201A (en) The use of resveratrol as sunscreen
IL152700A0 (en) Substituted 1-aminoalkyl-lactams and their use as muscarinc receptor antagonists
MXPA03009220A (en) Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors.
HK1076276A1 (en) 1-Amin-alkylcyclohexanes as 5-ht3 and neuronal nicotinicreceptor antagonists
IL156161A0 (en) Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
HUP0401756A3 (en) Substituted benzimidazole compounds and their use
AU2001252132A1 (en) Substituted 5-methyldihydropyridazinones and their use in the prophylaxis and/ortreatment of anemias
AU2003288974A8 (en) Compositions comprised of normal propyl bromide and 1,1,1,3,3-pentafluorobutane and uses thereof
HK1066022A1 (en) Use of 1,1,1,3,3-pentafluorobutan
AU2002302735A1 (en) 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists
HK1033876A1 (en) Use of nmda antagonists for treatment of irritablebowel syndrome.
AU782863C (en) The use of 5HT4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
AU782870C (en) The use of 5HT4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
AU2001233588A1 (en) New toralactone and its derivation and the use of decreasing blood-fat and losing weight
AU2002210763A1 (en) Use of 1-ebio in the treatment of bipolar disorders
MXPA03001288A (en) Use of starch compositions in papermaking.
HUP0303075A3 (en) Use of 5ht4 receptor antagonists in the manufacture of a medicament suitable for the prophylaxis or treatment of atrial fibrillation
AU2003300867A8 (en) Uses of the snorf207 receptor
AU2000236800A1 (en) Novel calcium antagonists
ZA200301031B (en) Use of 5HT4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation.
AU2003245995A1 (en) Use of gaba-c receptor antagonists for the treatment of myopia